Synopsis
Synopsis
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol
2. Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (e)-2-butenedioate (2:1) (salt)
3. Ici 204,636
4. Ici 204636
5. Ici-204636
6. Ici204636
7. Quetiapine
8. Seroquel
1. Quetiapine Hemifumarate
2. 111974-72-2
3. Seroquel
4. Ici-204636
5. Seroquel Xr
6. Ici 204,636
7. Quetiapine Fumarate [usan]
8. Zd5077
9. Utapine
10. Zm 204,636
11. Zm 204636
12. Quetiapine (as Fumarate)
13. Quetiapine Hemifumarate Salt
14. 2s3pl1b6uj
15. Quetiapine Fumarate (seroquel)
16. Fk947e
17. Fk-947e
18. Ici 204636
19. Zd-5077
20. Zm-204636
21. Chebi:8708
22. Fk949e
23. (2e)-but-2-enedioic Acid; Bis(2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,9,11,13-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol)
24. 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol Fumarate (2:1) (salt)
25. Unii-2s3pl1b6uj
26. Seroquel (tn)
27. 2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol
28. Mfcd03423782
29. Quetiapine Fumarate Salt
30. Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-, (2e)-2-butenedioate (2:1)
31. D00458
32. Quetiapine Fumarate Solution
33. 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol Hemifumarate
34. Dsstox_cid_24201
35. Dsstox_rid_80114
36. Dsstox_gsid_44201
37. Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (e)-2-butenedioate (2:1) (salt)
38. Schembl122596
39. Schembl390694
40. Chembl3188993
41. Dtxsid3044201
42. Quetiapine For System Suitability
43. Quetiapine Fumarate [jan]
44. Quetiapine Fumarate (jp17/usp)
45. Hms2089g04
46. Hms3713m10
47. Hms3884a10
48. Quetiapine Fumarate [vandf]
49. Bcp04154
50. Quetiapine Fumarate [mart.]
51. Quetiapine Hemifumarate [mi]
52. Tox21_302366
53. Quetiapine Fumarate [usp-rs]
54. Quetiapine Fumarate [who-dd]
55. S1763
56. Akos015855887
57. Ac-4236
58. Ccg-220464
59. Ks-1099
60. C21h25n3o2s.0.5c4h4o4
61. Ncgc00255945-01
62. Quetiapine Fumarate [orange Book]
63. As-12050
64. Quetiapine Fumarate [ep Monograph]
65. Quetiapine Fumarate [usp Monograph]
66. Cas-111974-72-2
67. Sw220283-1
68. Quetiapine Hemifumarate Salt, >=98% (hplc)
69. 974q697
70. J-002679
71. Q-201653
72. Q27108136
73. Quetiapine Fumarate 1.0 Mg/ml In Methanol (as Free Base)
74. Quetiapine Fumarate, European Pharmacopoeia (ep) Reference Standard
75. 2-[2-(4-dibenzo[b,f][1,4]thiazepin- 11-yl-1-piperazinyl)ethoxy]ethanol Hemifumarate
76. Bis(2-(2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethan-1-ol) Fumarate
77. Quetiapine For System Suitability, European Pharmacopoeia (ep) Reference Standard
78. Quetiapine Fumarate, Pharmaceutical Secondary Standard; Certified Reference Material
79. 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol Fumarate (2:1)
80. Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (e)-2-butenedioate (2:1)
81. Quetiapine Fumarate Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
82. Quetiapine Fumarate, United States Pharmacopeia (usp) Reference Standard, Monograph Mol Wt. 883.09 ((c21h25n3o2s)2 ?? C4h4o4)
Molecular Weight | 883.1 g/mol |
---|---|
Molecular Formula | C46H54N6O8S2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 14 |
Exact Mass | 882.34445505 g/mol |
Monoisotopic Mass | 882.34445505 g/mol |
Topological Polar Surface Area | 222 Ų |
Heavy Atom Count | 62 |
Formal Charge | 0 |
Complexity | 615 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 6 | |
---|---|
Drug Name | Quetiapine fumarate |
Drug Label | Quetiapine is a psychotropic agent belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [b,f ] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt). It is present in tablets... |
Active Ingredient | Quetiapine fumarate |
Dosage Form | Tablet, extended release; Tablet |
Route | oral; Oral |
Strength | eq 100mg base; 200mg; eq 50mg base; 150mg; eq 150mg base; 400mg; 300mg; eq 200mg base; 50mg; eq 300mg base; eq 400mg base; eq 25mg base |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Apotex; Accord Hlthcare; Alkem Labs; Handa Pharms; Aurobindo Pharma; Torrent Pharms; Lupin; Sandoz; Sun Pharma Global; Roxane; Actavis Grp Ptc; Teva Pharms; Jubilant Generics; Dr Reddys Labs |
2 of 6 | |
---|---|
Drug Name | Seroquel |
PubMed Health | Quetiapine (By mouth) |
Drug Classes | Antipsychotic |
Drug Label | SEROQUEL (quetiapine fumarate) is a psychotropic agent belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [b,f] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt). It... |
Active Ingredient | Quetiapine fumarate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 100mg base; eq 50mg base; eq 200mg base; eq 300mg base; eq 400mg base; eq 25mg base |
Market Status | Prescription |
Company | Astrazeneca |
3 of 6 | |
---|---|
Drug Name | Seroquel xr |
Drug Label | SEROQUEL XR (quetiapine fumarate) is a psychotropic agent belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [b,f ] [1,4] thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt).... |
Active Ingredient | Quetiapine fumarate |
Dosage Form | Tablet, extended release |
Route | oral; Oral |
Strength | 200mg; eq 50mg base; eq 150mg base; 400mg; 300mg; eq 200mg base; 50mg; eq 300mg base; eq 400mg base |
Market Status | Prescription |
Company | Astrazeneca |
4 of 6 | |
---|---|
Drug Name | Quetiapine fumarate |
Drug Label | Quetiapine is a psychotropic agent belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [b,f ] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt). It is present in tablets... |
Active Ingredient | Quetiapine fumarate |
Dosage Form | Tablet, extended release; Tablet |
Route | oral; Oral |
Strength | eq 100mg base; 200mg; eq 50mg base; 150mg; eq 150mg base; 400mg; 300mg; eq 200mg base; 50mg; eq 300mg base; eq 400mg base; eq 25mg base |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Apotex; Accord Hlthcare; Alkem Labs; Handa Pharms; Aurobindo Pharma; Torrent Pharms; Lupin; Sandoz; Sun Pharma Global; Roxane; Actavis Grp Ptc; Teva Pharms; Jubilant Generics; Dr Reddys Labs |
5 of 6 | |
---|---|
Drug Name | Seroquel |
PubMed Health | Quetiapine (By mouth) |
Drug Classes | Antipsychotic |
Drug Label | SEROQUEL (quetiapine fumarate) is a psychotropic agent belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [b,f] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt). It... |
Active Ingredient | Quetiapine fumarate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 100mg base; eq 50mg base; eq 200mg base; eq 300mg base; eq 400mg base; eq 25mg base |
Market Status | Prescription |
Company | Astrazeneca |
6 of 6 | |
---|---|
Drug Name | Seroquel xr |
Drug Label | SEROQUEL XR (quetiapine fumarate) is a psychotropic agent belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [b,f ] [1,4] thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt).... |
Active Ingredient | Quetiapine fumarate |
Dosage Form | Tablet, extended release |
Route | oral; Oral |
Strength | 200mg; eq 50mg base; eq 150mg base; 400mg; 300mg; eq 200mg base; 50mg; eq 300mg base; eq 400mg base |
Market Status | Prescription |
Company | Astrazeneca |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Antidepressive Agents
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17122
Submission : 2004-01-29
Status : Active
Type : II
Certificate Number : CEP 2014-200 - Rev 01
Issue Date : 2024-03-15
Type : Chemical
Substance Number : 2541
Status : Valid
Registration Number : 306MF10157
Registrant's Address : 8-2-337, Road No. 3,Banjara Hills,Hyderabad 500 034,TELANGANA,INDIA
Initial Date of Registration : 2024-12-11
Latest Date of Registration :
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0067
Address of the Firm :
NDC Package Code : 55111-053
Start Marketing Date : 2004-01-29
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Sangjin Corporation
Registration Date : 2012-06-28
Registration Number : 20120628-172-I-86-04
Manufacturer Name : Dr. Reddy's Laboratories Limited
Manufacturer Address : Chemical Technical Operations, Unit-VI, APIIC Industrial Estate, Pydibhimavaram, Ranasthalam Mandal, Srikakulam District - 532409, Andhra Pradesh, India.
Registration Number : 223MF10034
Registrant's Address : Area Industrial del Llobregat, C/Argent 1,08755 Castellbisbal Barcelona SPAIN
Initial Date of Registration : 2011-03-09
Latest Date of Registration :
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2013-03-15
Registration Number : 20130315-172-I-248-10
Manufacturer Name : INKE, SA
Manufacturer Address : Area Industrial del Llobregat, C/ Argent, 108755 CASTELLBISBAL, Barcelona, SPAIN
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19160
Submission : 2006-02-02
Status : Active
Type : II
Certificate Number : CEP 2015-170 - Rev 01
Issue Date : 2023-10-16
Type : Chemical
Substance Number : 2541
Status : Valid
NDC Package Code : 12780-4930
Start Marketing Date : 2006-02-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-12-01
Pay. Date : 2017-10-18
DMF Number : 32085
Submission : 2017-10-03
Status : Active
Type : II
Certificate Number : CEP 2017-175 - Rev 01
Issue Date : 2024-07-09
Type : Chemical
Substance Number : 2541
Status : Valid
Date of Issue : 2022-08-25
Valid Till : 2025-07-02
Written Confirmation Number : WC-0195
Address of the Firm :
NDC Package Code : 76072-1009
Start Marketing Date : 2017-06-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2020-06-30
Registration Number : 20200630-172-I-573-23
Manufacturer Name : ZCL Chemicals Limited
Manufacturer Address : 3102/B, GIDC Industrial Estate Ankleshwar City : Ankleshwar-393002 Dist : Bharuch, Gujarat State, India
Available Reg Filing : CN, AU |
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Certificate Number : R1-CEP 2016-049 - Rev 00
Issue Date : 2022-07-27
Type : Chemical
Substance Number : 2541
Status : Valid
Available Reg Filing : ASMF |
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37105
Submission : 2023-03-22
Status : Active
Type : II
Certificate Number : CEP 2023-102 - Rev 00
Issue Date : 2025-03-04
Type : Chemical
Substance Number : 2541
Status : Valid
NDC Package Code : 49716-335
Start Marketing Date : 2023-10-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17122
Submission : 2004-01-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19160
Submission : 2006-02-02
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25954
Submission : 2011-10-26
Status : Active
Type : II
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2017-12-01
Pay. Date : 2017-10-18
DMF Number : 32085
Submission : 2017-10-03
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37105
Submission : 2023-03-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24541
Submission : 2011-01-07
Status : Active
Type : II
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21336
Submission : 2008-02-12
Status : Active
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-23
Pay. Date : 2012-11-13
DMF Number : 18341
Submission : 2005-05-09
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-28
Pay. Date : 2013-09-18
DMF Number : 19516
Submission : 2006-06-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18797
Submission : 2005-09-12
Status : Inactive
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Certificate Number : CEP 2014-200 - Rev 01
Status : Valid
Issue Date : 2024-03-15
Type : Chemical
Substance Number : 2541
Certificate Number : CEP 2015-170 - Rev 01
Status : Valid
Issue Date : 2023-10-16
Type : Chemical
Substance Number : 2541
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Certificate Number : CEP 2017-175 - Rev 01
Status : Valid
Issue Date : 2024-07-09
Type : Chemical
Substance Number : 2541
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Certificate Number : R1-CEP 2016-049 - Rev 00
Status : Valid
Issue Date : 2022-07-27
Type : Chemical
Substance Number : 2541
Certificate Number : CEP 2023-102 - Rev 00
Status : Valid
Issue Date : 2025-03-04
Type : Chemical
Substance Number : 2541
Certificate Number : R1-CEP 2014-287 - Rev 00
Status : Valid
Issue Date : 2021-03-08
Type : Chemical
Substance Number : 2541
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
Certificate Number : R0-CEP 2019-291 - Rev 02
Status : Valid
Issue Date : 2023-07-10
Type : Chemical
Substance Number : 2541
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Certificate Number : CEP 2017-210 - Rev 04
Status : Valid
Issue Date : 2024-04-17
Type : Chemical
Substance Number : 2541
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Certificate Number : CEP 2020-234 - Rev 02
Status : Valid
Issue Date : 2023-12-19
Type : Chemical
Substance Number : 2541
Quetiapine Fumarate, Process III
Certificate Number : R0-CEP 2017-179 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2019-02-15
Type : Chemical
Substance Number : 2541
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0067
Address of the Firm : Chemical Technical Operations Unit-VI, APIIC Industrial Estate, Pydibhimavaram V...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Date of Issue : 2022-08-25
Valid Till : 2025-07-02
Written Confirmation Number : WC-0195
Address of the Firm : Plot No. 3102/B, GIDC, Industrial Estate, Ankleshwar-393 002, Bharuch, Gujarat I...
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
Date of Issue : 2023-01-06
Valid Till : 2025-07-29
Written Confirmation Number : WC-0099
Address of the Firm : Plot No. E-50, 50/1 and 59/1, Unit — IV, MIDC, Tarapur — 401506, Taluka: Pal...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Date of Issue : 2022-06-22
Valid Till : 2025-05-20
Written Confirmation Number : WC-0001
Address of the Firm : Q-1-4,Industrial area ,Ghinrongi Malanpur -477 117, Dist -Bhind (MP)
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Date of Issue : 2019-06-17
Valid Till : 2022-05-26
Written Confirmation Number : WC-0002
Address of the Firm : A-2, A-2/1, A-2/2, UPSIDC Industrial Area, Bijnor Road, Gajraula
Date of Issue : 2019-08-16
Valid Till : 2022-08-15
Written Confirmation Number : WC-0151
Address of the Firm : A-26/A 27, A-28/1, A-28/2, MIDC Industrial Area, Patalganga, Village Kare, Lal. ...
Date of Issue : 2022-09-30
Valid Till : 2025-09-10
Written Confirmation Number : WC-0201
Address of the Firm : T-142, MIDC, Tarapur, Vil: Boisar, Dist: Thane-401 506, Maharashtra State
Date of Issue : 2018-04-05
Valid Till : 2021-04-05
Written Confirmation Number : WC-316
Address of the Firm : Plot No.50-A,B,G & H, 64-A,B, C&D, 65-A,B,C&D, 66-A & B, 67-A & B, IDA, Kondapal...
Quetiapine Fumarate (USP/Ph. Eur.)
Date of Issue : 2020-03-13
Valid Till : 2023-01-05
Written Confirmation Number : WC-0384
Address of the Firm : Unit -IV Sy. No. 332,333 & 335, Velimindeu V Chityal Nalgonda District Telangan ...
Date of Issue : 2019-09-09
Valid Till : 2022-09-08
Written Confirmation Number : WC-0197
Address of the Firm : Plot No.1, Additional Phase MIDC, Mahad, Dist. Raigad-402 301, Maharashtra State...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Registrant Name : Sangjin Corporation
Registration Date : 2012-06-28
Registration Number : 20120628-172-I-86-04
Manufacturer Name : Dr. Reddy's Laboratories Lim...
Manufacturer Address : Chemical Technical Operations, Unit-VI, APIIC Industrial Estate, Pydibhimavaram, Rana...
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2013-03-15
Registration Number : 20130315-172-I-248-10
Manufacturer Name : INKE, SA
Manufacturer Address : Area Industrial del Llobregat, C/ Argent, 108755 CASTELLBISBAL, Barcelona, SPAI...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2020-06-30
Registration Number : 20200630-172-I-573-23
Manufacturer Name : ZCL Chemicals Limited
Manufacturer Address : 3102/B, GIDC Industrial Estate Ankleshwar City : Ankleshwar-393002 Dist : Bharuch, Gu...
Registrant Name : Korea Pharma Co., Ltd.
Registration Date : 2015-06-05
Registration Number : 20150605-172-I-456-16
Manufacturer Name : Moehs Cantabra, SL_x000D_
Manufacturer Address : Poligono Industrial Requejada, Polanco 39313 (Cantabria), Spain_x000D_
Registrant Name : Wooshin Labotech Co., Ltd.
Registration Date : 2019-06-11
Registration Number : 20150605-172-I-456-16(1)
Manufacturer Name : Moehs Cantabra, SL
Manufacturer Address : Poligono Industrial Requejada, Polanco 39313 (Cantabria), Spain
Registrant Name : Alvogen Korea Co., Ltd.
Registration Date : 2016-02-05
Registration Number : 20160205-172-I-463-18
Manufacturer Name : Ajinomoto Omnichem NV
Manufacturer Address : Cooppallaan 91, Wetteren, B-9230, Belgium
Registrant Name : Daewoong Bio Co., Ltd.
Registration Date : 2016-03-11
Registration Number : 20160311-172-I-482-19
Manufacturer Name : Fuan Pharmaceutical (Group) ...
Manufacturer Address : No.1 Huanan Yi Road, Changshou District, Chongqing 401254, China
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2016-10-27
Registration Number : 20160405-172-I-490-20(1)
Manufacturer Name : Qilu Tianhe Pharmaceutical C...
Manufacturer Address : No. 849 Dongjia Town, Licheng District, Jinan City, Shandong Province, PR China
Registrant Name : Sampoong Pharmachem Co., Ltd.
Registration Date : 2016-04-05
Registration Number : 20160405-172-I-490-20
Manufacturer Name : Qilu Tianhe Pharmaceutical C...
Manufacturer Address : No. 849 Dongjia Town, Licheng District, Jinan City, Shandong Province, PR China
Registrant Name : Hanmi Pharmaceutical Co., Ltd.
Registration Date : 2019-04-08
Registration Number : 20180730-172-I-550-21(1)
Manufacturer Name : Zhejiang Supor Pharmaceutica...
Manufacturer Address : Yuedong Road, Paojiang Industrial Zone, Shaoxing, Zhejiang 312071, China
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse the...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & F...
About the Company : Established in 1997, Temad Co. is one of the largest producers of APIs in Iran & an innovative manufacturer of narcotic and non-narcotic products of world-class quality in the Midd...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our...
About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering g...
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
About the Company : Egis is a member of the Servier Group. Egis’ products are manufactured at 3 production sites in Hungary, which are certified by EMA,FDA, ANVISA, PMDA ,KFDA. Egis sells its produc...
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
About the Company : Gonane Pharma, is a contract pharmaceutical company located in Gujarat, India, specializing in the manufacturing and marketing of Corticosteroids, Hormones, Antivirals, and Oncolog...
About the Company : With a history spanning over three decades, IOL Chemicals and Pharmaceuticals Limited is an innovation-driven company that specializes in bulk drugs, intermediates and specialty ch...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
1-[2-(2-Hydroxyethoxy)ethyl]Piperazine
CAS Number : 13349-82-1
End Use API : Quetiapine Hemifumarate
About The Company : Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owne...
Dibenzo[b,f][1,4]thiazepin 11 (10 H)-one
CAS Number : 3159-07-7
End Use API : Quetiapine Hemifumarate
About The Company : Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owne...
1-[2-(2-HYDROXY ETHOXY)ETHYL]PIPERAZINE
CAS Number : 13349-82-1
End Use API : Quetiapine Hemifumarate
About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...
DIBENZO[B,F][1,4]THIAZEPIN-11(10H)-ONE
CAS Number : 3159-07-7
End Use API : Quetiapine Hemifumarate
About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...
CAS Number : 40018-26-6
End Use API : Quetiapine Hemifumarate
About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...
Dibenzo[b,f][1,4]thiazepine-11(10-H)-one
CAS Number : 3159-07-7
End Use API : Quetiapine Hemifumarate
About The Company : Chemeca Drugs Private Limited was erstwhile M/s. Vegesna Laboratories Pvt Limited. M/s. Vegesna Laboratories Pvt Limited is a Private limited company having its...
1-(2-(2-hydroxy ethoxy) ethyl) piperzine
CAS Number : 13349-82-1
End Use API : Quetiapine Hemifumarate
About The Company : Chemeca Drugs Private Limited was erstwhile M/s. Vegesna Laboratories Pvt Limited. M/s. Vegesna Laboratories Pvt Limited is a Private limited company having its...
Dibenzo(b,f)(1,4)thiazepin-11(10H)-one
CAS Number : 3159-07-7
End Use API : Quetiapine Hemifumarate
About The Company : Delta Finochem Pvt Ltd. is a privately owned and professionally managed company, accredited by WHO-GMP & ISO 9001:2015 (Year of establishment 1994) Delta Finoch...
Dibenzo-[b,f][1,4]-thiazepin-11(10H)-one (DBT or D...
CAS Number : 3159-07-7
End Use API : Quetiapine Hemifumarate
About The Company : Elixir Pharma is founded in Sep 2009 by a group of seasoned, experienced techno commercial professionals in Ahmadabad, Gujarat (India). Elixir Pharma aspires to...
11-Piperazinyl dibenzo [b,f][1,4]thiazepine hydroc...
CAS Number : 111974-74-4
End Use API : Quetiapine Hemifumarate
About The Company : Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to thePharmaceu...
RLD : No
TE Code : AB
Brand Name : QUETIAPINE FUMARATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Approval Date : 2012-03-27
Application Number : 202152
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : QUETIAPINE FUMARATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 300MG BASE
Approval Date : 2013-02-12
Application Number : 201504
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : QUETIAPINE FUMARATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 300MG BASE
Approval Date : 2012-03-27
Application Number : 91388
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : Yes
TE Code : AB
Brand Name : SEROQUEL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 300MG BASE
Approval Date : 2000-07-26
Application Number : 20639
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : No
TE Code : AB
Brand Name : QUETIAPINE FUMARATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 50MG BASE
Approval Date : 2012-03-27
Application Number : 90749
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Brand Name : QUETIAPINE FUMARATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 400MG BASE
Approval Date : 2024-05-20
Application Number : 205983
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AB
Brand Name : QUETIAPINE FUMARATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG BASE
Approval Date : 2016-05-17
Application Number : 203359
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : QUETIAPINE FUMARATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 300MG BASE
Approval Date : 2022-08-24
Application Number : 206954
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : QUETIAPINE FUMARATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Approval Date : 2018-11-16
Application Number : 209635
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : QUETIAPINE FUMARATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Approval Date : 2012-03-27
Application Number : 77745
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Quetiapin XR Zentiva
Dosage Form : Ret Tabl
Dosage Strength : 150mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Quetiapin XR Zentiva
Dosage Form : Ret Tabl
Dosage Strength : 150mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Quetiapin XR Zentiva
Dosage Form : Ret Tabl
Dosage Strength : 300mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Quetiapin XR Zentiva
Dosage Form : Ret Tabl
Dosage Strength : 300mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Quetiapin XR Zentiva
Dosage Form : Ret Tabl
Dosage Strength : 50mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Quetiapine XR Zentiva
Dosage Form : Ret Tabl
Dosage Strength : 400mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Quetiapine Zentiva
Dosage Form : Filmtabl
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Quetiapine Zentiva
Dosage Form : Filmtabl
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Quetiapine Zentiva
Dosage Form : Filmtabl
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Quetiapine Zentiva
Dosage Form : Filmtabl
Dosage Strength : 25mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : Generic
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number : 77380
Regulatory Info : Generic
Registration Country : Canada
Regulatory Info : Generic
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 90749
Regulatory Info : Generic
Registration Country : Canada
Regulatory Info : Generic
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number : 201762
Regulatory Info : Generic
Registration Country : Canada
Regulatory Info : Generic
Registration Country : Canada
Brand Name :
Dosage Form : TABLET
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number : 202152
Regulatory Info : Generic
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
QUETIAPINE (QUETIAPINE FUMARATE)
Brand Name : ACH-QUETIAPINE FUMARATE XR
Dosage Form : TABLET (EXTENDED-RELEASE)
Dosage Strength : 300MG
Packaging : 60/100/1000
Approval Date :
Application Number : 2450895
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
QUETIAPINE (QUETIAPINE FUMARATE)
Brand Name : APO-QUETIAPINE XR
Dosage Form : TABLET (EXTENDED-RELEASE)
Dosage Strength : 50MG
Packaging : 60
Approval Date :
Application Number : 2457229
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
QUETIAPINE (QUETIAPINE FUMARATE)
Brand Name : APO-QUETIAPINE FUMARATE
Dosage Form : TABLET (IMMEDIATE RELEASE)
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number : 2501651
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
QUETIAPINE (QUETIAPINE FUMARATE)
Brand Name : JAMP-QUETIAPINE
Dosage Form : TABLET (IMMEDIATE RELEASE)
Dosage Strength : 100MG
Packaging : 100/500
Approval Date :
Application Number : 2330423
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
QUETIAPINE (QUETIAPINE FUMARATE)
Brand Name : NRA-QUETIAPINE XR
Dosage Form : TABLET (EXTENDED-RELEASE)
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number : 2510715
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
QUETIAPINE (QUETIAPINE FUMARATE)
Brand Name : QUETIAPINE FUMARATE XR
Dosage Form : TABLET (EXTENDED-RELEASE)
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 2516616
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info :
Registration Country : Australia
Brand Name : Syquet
Dosage Form : tablet
Dosage Strength : 200 mg
Packaging : 60
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Seroquel XR
Dosage Form :
Dosage Strength :
Packaging : 60
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Quetiapine APOTEX
Dosage Form : tablet
Dosage Strength : 300 mg
Packaging : 60
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : APX-Quetiapine XR
Dosage Form :
Dosage Strength :
Packaging : 60
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : APX-Quetiapine XR
Dosage Form :
Dosage Strength :
Packaging : 60
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Quetia XR
Dosage Form :
Dosage Strength :
Packaging : 60
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Quetia XR
Dosage Form :
Dosage Strength :
Packaging : 60
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Pharmacor Quetiapine 100
Dosage Form : tablet
Dosage Strength : 100 mg
Packaging : 90
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Quetiapine Sandoz XR
Dosage Form :
Dosage Strength :
Packaging : 60
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Quetiapine Sandoz Pharma
Dosage Form : tablet
Dosage Strength : 25 mg
Packaging : 60
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Seroquel Xr 50
Dosage Form : TAB
Dosage Strength : 50mg
Packaging : 10X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Seroquel Xr 300
Dosage Form : TAB
Dosage Strength : 300mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Truvalin XR 200
Dosage Form : TAB
Dosage Strength : 200mg
Packaging : 60X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Quetz 200 mg
Dosage Form : TAB
Dosage Strength : 200mg
Packaging : 60X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Quesara 100 mg
Dosage Form : FCT
Dosage Strength : 100mg
Packaging : 90X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Spec Quetiapine 150
Dosage Form : FCT
Dosage Strength : 150mg
Packaging : 90X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : SIZONORM 25 mg
Dosage Form : TAB
Dosage Strength : 25mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Torquit 25
Dosage Form : TAB
Dosage Strength : 25mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Torquit 100
Dosage Form : TAB
Dosage Strength : 100mg
Packaging : 90X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Kizofrin 300 mg
Dosage Form : TAB
Dosage Strength : 300mg
Packaging : 60X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Packaging :
Regulatory Info : Registered in EU
Dosage : Film Coated Tablet
Dosage Strength : 25MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Packaging :
Regulatory Info : Registered in EU
Dosage : Film Coated Tablet
Dosage Strength : 100MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Packaging :
Regulatory Info : Registered in EU
Dosage : Film Coated Tablet
Dosage Strength : 150MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Packaging :
Regulatory Info : Registered in EU
Dosage : Film Coated Tablet
Dosage Strength : 200MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Packaging :
Regulatory Info : Registered in EU
Dosage : Film Coated Tablet
Dosage Strength : 300MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Germany
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Regulatory Info : Generic
Registration Country : New Zealand
Brand Name :
Dosage Form : TABLET
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : New Zealand
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 25MG
Brand Name :
Approval Date :
Application Number :
Registration Country : New Zealand
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Regulatory Info : Generic
Registration Country : New Zealand
Brand Name :
Dosage Form : TABLET
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : New Zealand
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 100MG
Brand Name :
Approval Date :
Application Number :
Registration Country : New Zealand
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Regulatory Info : Generic
Registration Country : New Zealand
Brand Name :
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : New Zealand
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 200MG
Brand Name :
Approval Date :
Application Number :
Registration Country : New Zealand
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Regulatory Info : Generic
Registration Country : New Zealand
Brand Name :
Dosage Form : TABLET
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : New Zealand
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 300MG
Brand Name :
Approval Date :
Application Number :
Registration Country : New Zealand
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Quetiapine Hemifumarat...
Dosage Form : DC Granules
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Packaging :
Regulatory Info :
Dosage : DC Granules
Dosage Strength : 100MG
Brand Name : Quetiapine Hemifumarat...
Approval Date :
Application Number :
Registration Country : India
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Cream / Lotion / Ointment
Grade : Oral, Topical & Parenteral
Brand Name : PEG/Macrogol 4000
Application : Emulsifying Agents
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Polyethylene Glycol 4000
Excipients by Applications
Global Sales Information
Market Place
Reply
02 Jan 2023
Reply
02 Dec 2022
Reply
12 May 2022
Reply
22 Feb 2022
Reply
07 Feb 2022
Reply
11 Aug 2021
Reply
09 Aug 2021
Reply
01 Jun 2021
Reply
02 Dec 2020
Reply
23 Sep 2019
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
88
PharmaCompass offers a list of Quetiapine Fumarate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Quetiapine Fumarate manufacturer or Quetiapine Fumarate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Quetiapine Fumarate manufacturer or Quetiapine Fumarate supplier.
PharmaCompass also assists you with knowing the Quetiapine Fumarate API Price utilized in the formulation of products. Quetiapine Fumarate API Price is not always fixed or binding as the Quetiapine Fumarate Price is obtained through a variety of data sources. The Quetiapine Fumarate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Quetiapine Fumarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Quetiapine Fumarate, including repackagers and relabelers. The FDA regulates Quetiapine Fumarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Quetiapine Fumarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Quetiapine Fumarate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Quetiapine Fumarate supplier is an individual or a company that provides Quetiapine Fumarate active pharmaceutical ingredient (API) or Quetiapine Fumarate finished formulations upon request. The Quetiapine Fumarate suppliers may include Quetiapine Fumarate API manufacturers, exporters, distributors and traders.
click here to find a list of Quetiapine Fumarate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Quetiapine Fumarate DMF (Drug Master File) is a document detailing the whole manufacturing process of Quetiapine Fumarate active pharmaceutical ingredient (API) in detail. Different forms of Quetiapine Fumarate DMFs exist exist since differing nations have different regulations, such as Quetiapine Fumarate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Quetiapine Fumarate DMF submitted to regulatory agencies in the US is known as a USDMF. Quetiapine Fumarate USDMF includes data on Quetiapine Fumarate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Quetiapine Fumarate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Quetiapine Fumarate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Quetiapine Fumarate Drug Master File in Japan (Quetiapine Fumarate JDMF) empowers Quetiapine Fumarate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Quetiapine Fumarate JDMF during the approval evaluation for pharmaceutical products. At the time of Quetiapine Fumarate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Quetiapine Fumarate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Quetiapine Fumarate Drug Master File in Korea (Quetiapine Fumarate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Quetiapine Fumarate. The MFDS reviews the Quetiapine Fumarate KDMF as part of the drug registration process and uses the information provided in the Quetiapine Fumarate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Quetiapine Fumarate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Quetiapine Fumarate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Quetiapine Fumarate suppliers with KDMF on PharmaCompass.
A Quetiapine Fumarate CEP of the European Pharmacopoeia monograph is often referred to as a Quetiapine Fumarate Certificate of Suitability (COS). The purpose of a Quetiapine Fumarate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Quetiapine Fumarate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Quetiapine Fumarate to their clients by showing that a Quetiapine Fumarate CEP has been issued for it. The manufacturer submits a Quetiapine Fumarate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Quetiapine Fumarate CEP holder for the record. Additionally, the data presented in the Quetiapine Fumarate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Quetiapine Fumarate DMF.
A Quetiapine Fumarate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Quetiapine Fumarate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Quetiapine Fumarate suppliers with CEP (COS) on PharmaCompass.
A Quetiapine Fumarate written confirmation (Quetiapine Fumarate WC) is an official document issued by a regulatory agency to a Quetiapine Fumarate manufacturer, verifying that the manufacturing facility of a Quetiapine Fumarate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Quetiapine Fumarate APIs or Quetiapine Fumarate finished pharmaceutical products to another nation, regulatory agencies frequently require a Quetiapine Fumarate WC (written confirmation) as part of the regulatory process.
click here to find a list of Quetiapine Fumarate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Quetiapine Fumarate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Quetiapine Fumarate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Quetiapine Fumarate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Quetiapine Fumarate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Quetiapine Fumarate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Quetiapine Fumarate suppliers with NDC on PharmaCompass.
Quetiapine Fumarate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Quetiapine Fumarate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Quetiapine Fumarate GMP manufacturer or Quetiapine Fumarate GMP API supplier for your needs.
A Quetiapine Fumarate CoA (Certificate of Analysis) is a formal document that attests to Quetiapine Fumarate's compliance with Quetiapine Fumarate specifications and serves as a tool for batch-level quality control.
Quetiapine Fumarate CoA mostly includes findings from lab analyses of a specific batch. For each Quetiapine Fumarate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Quetiapine Fumarate may be tested according to a variety of international standards, such as European Pharmacopoeia (Quetiapine Fumarate EP), Quetiapine Fumarate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Quetiapine Fumarate USP).